AZTR (Azitra) Total Equity: $10.48 Mil (As of Mar. 2026)


AZTR Azitra Inc AZTR
35 GF Score
Price $0.15
! 1 Warning Sign
View Full Analysis

What is Azitra Total Equity?

Azitra AZTR -9.30% 35 Total Equity is $10.48 Mil as of Mar. 2026. GuruFocus rates AZTR with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

Azitra's total equity for the quarter that ended in Mar. 2026 was $10.48 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Azitra Total Equity Historical Data

* Premium members only.

The historical data trend for Azitra's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azitra Total Equity Chart

Azitra Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
-25.77 -36.26 2.91 5.70 3.80

Azitra Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.41 2.23 2.28 3.80 10.48
AZTR
35GF Score
Azitra Inc AZTR
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azitra Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Azitra's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5.025-1.224
=3.80

Azitra's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=12.127-1.647
=10.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $10.48 Mil mean?
Azitra (AZTR) has a Total Equity of $10.48 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Azitra and its competitors.
Is Azitra's Total Equity too high?
Azitra's current Total Equity is $10.48 Mil. Overall, Azitra has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Azitra's Total Equity compare to CASIF and ITRMF?
Azitra's Total Equity of $10.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Azitra and its competitors. Azitra's current Total Equity is $10.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azitra stock overvalued right now?
Azitra (AZTR) has a current Total Equity of $10.48 Mil. The current Total Equity is $10.48 Mil. Azitra's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Azitra (AZTR), the current Total Equity is $10.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Azitra Business Description

Address 21 Business Park Drive, Branford, CT, USA, 06405
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
35GF Score

Get the complete analysis for AZTR

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price